Bárbara Herranz‐Blanco

No ORCID on file · 4 papers in corpus · active 2023-2024

Study types

  • article 2
  • preprint 2

Condition tags

  • endometriosis 4
  • mesh:D004715 2
preprint 2024
Validation of an in vitro diagnostic test for endometriosis: impact of confounding medical conditions and lesion location
·doi:10.1101/2024.04.17.24305952

Abstract With the aim to shorten the time for diagnosis and accelerate access to correct management, a non-invasive diagnostic test for endometriosis was developed and validated. The IVD test combines an ELISA test kit to quantify CA125 and…

article 2024
Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location
International journal of molecular sciences ·doi:10.3390/ijms25147667

With the aim to shorten the time for diagnosis and accelerate access to correct management, a non-invasive diagnostic test for endometriosis was developed and validated. The IVD test combines an ELISA test kit to quantify CA125 and BDNF con…

article 2023
Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables
Biomolecules ·doi:10.3390/biom13071052

Endometriosis affects more than 10% of women of reproductive age, significantly impacting their quality of life. Diagnosis typically takes 4 to 11 years from symptom onset. The gold standard for diagnosing this disease, laparoscopy, is inva…

preprint 2023
Development and Validation of a novel in vitro diagnostic test for endometriosis
·doi:10.1101/2023.03.29.23287909

STRUCTURED ABSTRACT Objective To develop a non-invasive diagnostic test for endometriosis. Design We conducted two studies: the development study (study 1) aimed at (i) evaluating the ability of CA125, brain-derived neurotrophic factor (BDN…